Nicholas Kunda, MD
Plastic Surgery · Great Neck, NYNPI 1902242407
Payments from drug & device makers
What this record shows
This record is dominated by grants: $7,500 of the $11,022 with a category attached, or 68.0%. Arthrex accounts for 68.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $7,765 and has fallen 66.6% since, to $2,592 in 2025.
Across 50 payments — averaging $220.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$8K
- TELA Bio, Inc.$2K
- Axogen$314
- Polynovo North America LLC$261
- AbbVie$216
- Checkpoint Surgical, Inc$106
- plus $696 from 17 others
What the payments were for
- Grants$7,50068%
- Travel & lodging$1,68215%
- Food & beverage$1,84017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $7,500 |
| TELA Bio, Inc. | 6 | $1,930 |
| Axogen | 4 | $314 |
| Polynovo North America LLC | 3 | $261 |
| AbbVie | 7 | $216 |
| Checkpoint Surgical, Inc | 2 | $106 |
| Davol Inc. | 3 | $87 |
| Integra Lifesciences Corporation | 3 | $82 |
| Endo USA, Inc. | 3 | $72 |
| Convatec Inc. | 2 | $53 |
| Organogenesis Inc. | 2 | $48 |
| Innovation Technologies Inc | 1 | $47 |
| Endo Pharmaceuticals Inc. | 2 | $47 |
| Motiva USA, LLC | 1 | $45 |
| Stryker | 1 | $42 |
| Mimedx Group, Inc. | 2 | $37 |
| Coopersurgical, Inc. | 1 | $25 |
| Dilon Technologies, Inc. | 1 | $24 |
| Acumed LLC | 1 | $23 |
| Johnson & Johnson | 1 | $18 |
| Sonex Health, Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,022 in reported general payments places this provider in the 80th percentile of 363 plastic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 23 | $161 |
| Tramadol Hcl | 38 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Great Neck
- Jonathan BankGreat Neck$109K
- Ron IsraeliGreat Neck$35K
- Sachin ShridharaniNew York$1.1M
- Scot GlasbergNew York$959K
- Nolan KarpNew York$900K
- Michael LacquaBrooklyn$865K
- Sydney ColemanNew York$729K
- David RapaportNew York$578K
- Richard SwiftNew York$487K
- Michael KaneNew York$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.